Attention Deficit Hyperactivity Disorder (DSM-IV) and Hyperkinetic Disorder (ICD-10) are common conditions with a high morbidity which impact on the lives of the affected children, their families and schools, and have important implications for wider society. Behavioural, psychological and medical treatments are available and there is a sound evidence base for drug treatments. NICE guidance is available. This review summarises what is known about the condition, available treatments and common dilemmas which may be faced by a general or community paediatrician who has some interest in behavioural disorders.
Paul Davis MD MB BCH MRCP FRCPCH DRCOG DCH is a Consultant in General and Community Paediatrics, The Children's Centre, St David's Hospital, Cardiff, UK
Azra Sabir MB BS MRCPsych is a Consultant Child and Adolescent Psychiatrist, CAMHS, St David's Hospital, Cardiff, UK